The role of MicroRNAs in cancer susceptibility

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Iuliano, Rodolfo ^a   Vismara, Marco Flavio Michele ^a,b   Dattilo, Vincenzo ^a   Trapasso, Francesco ^a   Baudi, Francesco ^a,c   Perrotti, Nicola ^a  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c Centro Oncologico Fondazione T Campanella   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; MICRORNA; MICRORNA 146A; RAD52 PROTEIN;

3' UNTRANSLATED REGION; ARTICLE; BLADDER CANCER; BREAST CANCER; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CELL PROLIFERATION; COLORECTAL CARCINOMA; DNA SEQUENCE; DOWN REGULATION; ESOPHAGUS CANCER; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOME ANALYSIS; GENOTYPE; HAPLOTYPE; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HOMOLOGOUS RECOMBINATION; HUMAN; KIDNEY CARCINOMA; LUNG NON SMALL CELL CANCER; MELANOMA; MUTATIONAL ANALYSIS; NASOPHARYNX CARCINOMA; OVERALL SURVIVAL; PROMOTER REGION; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN TARGETING; RNA ANALYSIS; RNA PROCESSING; SINGLE NUCLEOTIDE POLYMORPHISM; THYROID CARCINOMA; BINDING SITE; GENETIC PREDISPOSITION; GENETICS; HUMAN GENOME; MUTATION; NEOPLASM; REVIEW;

3' UNTRANSLATED REGIONS; BINDING SITES; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; HUMANS; MICRORNAS; MUTATION; NEOPLASMS;

EID: 84876568840     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/591931     Document Type: Article

References (70)

1. Kim V. N., Han J., Siomi M. C., Biogenesis of small RNAs in animals. Nature Reviews Molecular Cell Biology 2009 10 2 126 139
2. Gregory R. I., Yan K. P., Amuthan G., The Microprocessor complex mediates the genesis of microRNAs. Nature 2004 432 7014 235 240 (Pubitemid 39545855)
3. Brennecke J., Stark A., Russell R. B., Cohen S. M., Principles of microRNA-target recognition. PLoS Biology 2005 3 3, article e85 2-s2.0-24644482193
4. Johnson S. M., Grosshans H., Shingara J., Byrom M., Jarvis R., Cheng A., Labourier E., Reinert K. L., Brown D., Slack F. J., RAS is regulated by the let-7 microRNA family. Cell 2005 120 5 635 647 2-s2.0-20044395613 10.1016/j.cell.2005.01.014 (Pubitemid 40343076)
5. Cimmino A., Calin G. A., Fabbri M., Iorio M. V., Ferracin M., Shimizu M., Wojcik S. E., Aqeilan R. I., Zupo S., Dono M., Rassenti L., Alder H., Volinia S., Liu C. G., Kipps T. J., Negrini M., Croce C. M., miR-15 and miR-16 induce apoptosis by targeting BCL2. Proceedings of the National Academy of Sciences of the United States of America 2005 102 39 13944 13949 2-s2.0-25444520537 10.1073/pnas.0506654102 (Pubitemid 41377683)
6. Olive V., Bennett M. J., Walker J. C., Ma C., Jiang I., Cordon-Cardo C., Li Q. J., Lowe S. W., Hannon G. J., He L., miR-19 is a key oncogenic component of mir-17-92. Genes and Development 2009 23 24 2839 2849 2-s2.0-72849120988 10.1101/gad.1861409
7. Visone R., Russo L., Pallante P., De Martino I., Ferraro A., Leone V., Borbone E., Petrocca F., Alder H., Croce C. M., Fusco A., MicroRNAs (miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycle. Endocrine-Related Cancer 2007 14 3 791 798 2-s2.0-35948975794 10.1677/ERC-07-0129 (Pubitemid 350074067)
8. Paduano F., Dattilo V., Narciso D., Protein tyrosine phosphatase PTPRJ is negatively regulated by microRNA-328. The FEBS Journal 2013 280 2 401 412
9. Garzon R., Calin G. A., Croce C. M., MicroRNAs in cancers. Annual Review of Medicine 2009 60 167 179
10. Fabbri M., Valeri N., Calin G. A., MicroRNAs and genomic variations: from proteus tricks to prometheus gift. Carcinogenesis 2009 30 6 912 917 2-s2.0-66749112300 10.1093/carcin/bgp063
11. Jazdzewski K., Murray E. L., Franssila K., Jarzab B., Schoenberg D. R., De La Chapelle A., Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma. Proceedings of the National Academy of Sciences of the United States of America 2008 105 20 7269 7274 2-s2.0-44449153200 10.1073/pnas.0802682105 (Pubitemid 351754467)
12. Wang M., Chu H., Li P., Genetic variants in miRNAs predict bladder cancer risk and recurrence. Cancer Research 2012 72 23 6173 6182
13. Lung R. W., Wang X., Tong J. H., A single nucleotide polymorphism in microRNA-146a is associated with the risk for nasopharyngeal carcinoma. Molecular Carcinogenesis 2012
14. Pastrello C., Polesel J., Puppa L. D., Viel A., Maestro R., Association between hsa-mir-146a genotype and tumor age-of-onset in BRCA1/BRCA2-negative familial breast and ovarian cancer patients. Carcinogenesis 2010 31 12 2124 2126 2-s2.0-78649773520 10.1093/carcin/bgq184
15. Catucci I., Yang R., Verderio P., Pizzamiglio S., Heesen L., Hemminki K., Sutter C., Wappenschmidt B., Dick M., Arnold N., Bugert P., Niederacher D., Meindl A., Schmutzler R. K., Bartram C. C., Ficarazzi F., Tizzoni L., Zaffaroni D., Manoukian S., Barile M., Pierotti M. A., Radice P., Burwinkel B., Peterlongo P., Evaluation of SNPs in miR-146a, miR196a2 and miR-499 as low-penetrance alleles in German and Italian familial breast cancer cases. Human Mutation 2010 31 1 E1052 E1057 2-s2.0-74049157786 10.1002/humu.21141
16. Garcia A. I., Cox D. G., Barjhoux L., The rs2910164:G >C SNP in the MIR146A gene is not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers. Human Mutation 2011
17. Lian H., Wang L., Zhang J., Increased risk of breast cancer associated with CC genotype of Has-miR-146a Rs2910164 polymorphism in Europeans. PLoS ONE 2012 7 2 e31615
18. Wang Z., Cao Y., Jiang C., Yang G., Wu J., Ding Y., Lack of association of two common polymorphisms rs2910164 and rs11614913 with susceptibility to hepatocellular carcinoma: a meta-analysis. PLoS ONE 2012 7 6 e40039
19. Hu Z., Chen J., Tian T., Zhou X., Gu H., Xu L., Zeng Y., Miao R., Jin G., Ma H., Chen Y., Shen H., Genetic variants of miRNA sequences and non-small cell lung cancer survival. Journal of Clinical Investigation 2008 118 7 2600 2608 2-s2.0-46749147615 10.1172/JC134934 (Pubitemid 351949787)
20. Vinci S., Gelmini S., Pratesi N., Genetic variants in miR-146a, miR-149, miR-196a2, miR-499 and their influence on relative expression in lung cancers. Clinical Chemistry and Laboratory Medicine 2011 49 12 2073 2080
21. Christensen B. C., Avissar-Whiting M., Ouellet L. G., Butler R. A., Nelson H. H., McClean M. D., Marsit C. J., Kelsey K. T., Mature microRNA sequence polymorphism in MIR196A2 is associated with risk and prognosis of head and neck cancer. Clinical Cancer Research 2010 16 14 3713 3720 2-s2.0-77954752364 10.1158/1078-0432.CCR-10-0657
22. Min K. T., Kim J. W., Jeon Y. J., Association of the miR-146aC>G, 149C>T, 196a2C>T, and 499A>G polymorphisms with colorectal cancer in the Korean population. Molecular Carcinogenesis 2012 51 1 E65 E73
23. Hu Z., Liang J., Wang Z., Tian T., Zhou X., Chen J., Miao R., Wang Y., Wang X., Shen H., Common genetic variants in pre-microRNAs were associated with increased risk of breast cancer in Chinese women. Human Mutation 2009 30 1 79 84 2-s2.0-58349104128 10.1002/humu.20837
24. Chu H., Wang M., Shi D., Ma L., Zhang Z., Tong N., Huo X., Wang W., Luo D., Gao Y., Zhang Z., Hsa-miR-196a2 Rs11614913 polymorphism contributes to cancer susceptibility: evidence from 15 case-control studies. PLoS ONE 2011 6 3 2-s2.0-79953312694 10.1371/journal.pone.0018108 e18108
25. Ye Y., Wang K. K., Gu J., Yang H., Lin J., Ajani J. A., Wu X., Genetic variations in microRNA-related genes are novel susceptibility loci for esophageal cancer risk. Cancer Prevention Research 2008 1 6 460 469 2-s2.0-61749093062 10.1158/1940-6207.CAPR-08-0135
26. Smith R. A., Jedlinski D. J., Gabrovska P. N., Weinstein S. R., Haupt L., Griffiths L. R., A genetic variant located in miR-423 is associated with reduced breast cancer risk. Cancer Genomics Proteomics 2012 9 3 115 118
27. Xing J., Wan S., Zhou F., Genetic polymorphisms in pre-microRNA genes as prognostic markers of colorectal cancer. Cancer Epidemiology, Biomarkers & Prevention 2012 21 1 217 227
28. Wang F., Sun G., Zou Y., Li Y., Hao L., Pan F., Association of microRNA-499 rs3746444 polymorphism with cancer risk: evidence from 7188 cases and 8548 controls. PLoS ONE 2012 7 9 e45042
29. Zhou B., Wang K., Wang Y., Xi M., Zhang Z., Song Y., Zhang L., Common genetic polymorphisms in pre-microRNAs and risk of cervical squamous cell carcinoma. Molecular Carcinogenesis 2011 50 7 499 505 2-s2.0-79958199899 10.1002/mc.20740
30. Lin M., Gu J., Eng C., Genetic polymorphisms in MicroRNA-related genes as predictors of clinical outcomes in colorectal adenocarcinoma patients. Clinical Cancer Research 2012 18 14 3982 3991
31. Ryan B. M., McClary A. C., Valeri N., rs4919510 in hsa-mir-608 is associated with outcome but not risk of colorectal cancer. PLoS ONE 2012 7 5 e36306
32. Huang A. J., Yu K. D., Li J., Fan L., Shao Z. M., Polymorphism rs4919510:C>G in mature sequence of human microRNA-608 contributes to the risk of HER2-positive breast cancer but not other subtypes. PLoS ONE 2012 7 5 e35252
33. Yang R., Schlehe B., Hemminki K., Sutter C., Bugert P., Wappenschmidt B., Volkmann J., Varon R., Weber B. H. F., Niederacher D., Arnold N., Meindl A., Bartram C. R., Schmutzler R. K., Burwinkel B., A genetic variant in the pre-miR-27a oncogene is associated with a reduced familial breast cancer risk. Breast Cancer Research and Treatment 2010 121 3 693 702 2-s2.0-77953122376 10.1007/s10549-009-0633-5
34. Catucci I., Verderio P., Pizzamiglio S., The SNP rs895819 in miR-27a is not associated with familial breast cancer risk in Italians. Breast Cancer Research and Treatment 2012 133 2 805 807
35. Yang R., Burwinkel B., A bias in genotyping the miR-27a rs895819 and rs11671784 variants. Breast Cancer Research and Treatment 2012 134 2 899 901
36. Shi D., Li P., Ma L., A genetic variant in pre-miR-27a is associated with a reduced renal cell cancer risk in a Chinese population. PLoS ONE 2012 7 10 e46566
37. Sun Q., Gu H., Zeng Y., Xia Y., Wang Y., Jing Y., Yang L., Wang B., Hsa-mir-27a genetic variant contributes to gastric cancer susceptibility through affecting miR-27a and target gene expression. Cancer Science 2010 101 10 2241 2247 2-s2.0-77957028035 10.1111/j.1349-7006.2010.01667.x
38. Chin L. J., Ratner E., Leng S., Zhai R., Nallur S., Babar I., Muller R. U., Straka E., Su L., Burki E. A., Crowell R. E., Patel R., Kulkarni T., Homer R., Zelterman D., Kidd K. K., Zhu Y., Christiani D. C., Belinsky S. A., Slack F. J., Weidhaas J. B., A SNP in a let-7 microRNA complementary site in the KRAS 3 ′ untranslated region increases non-small cell lung cancer risk. Cancer Research 2008 68 20 8535 8540 2-s2.0-54249117763 10.1158/0008-5472.CAN-08-2129
39. Hollestelle A., Pelletier C., Hooning M., Crepin E., Schutte M., Look M., Collee J. M., Nieuwlaat A., Dorssers L. C. J., Seynaeve C., Aulchenko Y. S., Martens J. W. M., Van Den Ouweland A. M. W., Weidhaas J. B., Prevalence of the variant allele rs61764370 T>G in the 3 ′ UTR of KRAS among Dutch BRCA1, BRCA2 and non-BRCA1/BRCA2 breast cancer families. Breast Cancer Research and Treatment 2011 128 1 79 84 2-s2.0-79959210731 10.1007/s10549-010-1080-z
40. Smits K. M., Paranjape T., Nallur S., A let-7 microRNA SNP in the KRAS 3 ′ UTR is prognostic in early-stage colorectal cancer. Clinical Cancer Research 2011 17 24 7723 7731
41. Chan E., Patel R., Nallur S., MicroRNA signatures differentiate melanoma subtypes. Cell Cycle 2011 10 11 1854 1852
42. Christensen B. C., Moyer B. J., Avissar M., Ouellet L. G., Plaza S. L., Mcclean M. D., Marsit C. J., Kelsey K. T., A let-7 microRNA-binding site polymorphism in the KRAS 3 ′ UTR is associated with reduced survival in oral cancers. Carcinogenesis 2009 30 6 1003 1007 2-s2.0-66749164641 10.1093/carcin/bgp099
43. Ratner E. S., Keane F. K., Lindner R., A KRAS variant is a biomarker of poor outcome, platinum chemotherapy resistance and a potential target for therapy in ovarian cancer. Oncogene 2012 31 42 4559 4566
44. Kjersem J. B., Ikdahl T., Guren T., Let-7 miRNA-binding site polymorphism in the KRAS 3 ′ UTR; colorectal cancer screening population prevalence and influence on clinical outcome in patients with metastatic colorectal cancer treated with 5-fluorouracil and oxaliplatin +/- cetuximab. BMC Cancer 2012 12 1 534 541
45. Nelson H. H., Christensen B. C., Plaza S. L., Wiencke J. K., Marsit C. J., Kelsey K. T., KRAS mutation, KRAS-LCS6 polymorphism, and non-small cell lung cancer. Lung Cancer 2010 69 1 51 53 2-s2.0-77953362059 10.1016/j.lungcan.2009. 09.008
46. Permuth-Wey J., Chen Z., Tsai Y. Y., MicroRNA processing and binding site polymorphisms are not replicated in the Ovarian Cancer Association Consortium. Cancer Epidemiology, Biomarkers & Prevention 2011 20 8 1793 1797
47. Nicoloso M. S., Sun H., Spizzo R., Kim H., Wickramasinghe P., Shimizu M., Wojcik S. E., Ferdin J., Kunej T., Xiao L., Manoukian S., Secreto G., Ravagnani F., Wang X., Radice P., Croce C. M., Davuluri R. V., Calin G. A., Single-nucleotide polymorphisms inside microRNA target sites influence tumor susceptibility. Cancer Research 2010 70 7 2789 2798 2-s2.0-77950822671 10.1158/0008-5472.CAN-09-3541
48. Valle L., Serena-Acedo T., Liyanarachchi S., Hampel H., Comeras I., Li Z., Zeng Q., Zhang H. T., Pennison M. J., Sadim M., Pasche B., Tanner S. M., De La Chapelle A., Germline allele-specific expression of TGFBR1 confers an increased risk of colorectal cancer. Science 2008 321 5894 1361 1365 2-s2.0-51149099981 10.1126/science.1159397
49. Xiong F., Wu C., Chang J., Yu D., Xu B., Yuan P., Zhai K., Xu J., Tan W., Lin D., Genetic variation in an miRNA-1827 binding site in MYCL1 alters susceptibility to small-cell lung cancer. Cancer Research 2011 71 15 5175 5181 2-s2.0-79960962854 10.1158/0008-5472.CAN-10-4407
50. Jiang Y., Qin Z., Hu Z., Genetic variation in a hsa-let-7 binding site in RAD52 is associated with breast cancer susceptibility. Carcinogenesis 2012
51. Song F., Zheng H., Liu B., Wei S., Dai H., Zhang L., Calin G. A., Hao X., Wei Q., Zhang W., Chen K., An miR-502-binding site single-nucleotide polymorphism in the 3 ′ -untranslated region of the SET8 gene is associated with early age of breast cancer onset. Clinical Cancer Research 2009 15 19 6292 6300 2-s2.0-70349682881 10.1158/1078-0432.CCR-09-0826
52. Shi X., Kachirskaia I., Yamaguchi H., West L. E., Wen H., Wang E. W., Dutta S., Appella E., Gozani O., Modulation of p53 function by SET8-mediated methylation at lysine 382. Molecular Cell 2007 27 4 636 646 2-s2.0-34547809957 10.1016/j.molcel.2007.07.012 (Pubitemid 47238634)
53. Guo Z., Wu C., Wang X., Wang C., Zhang R., Shan B., A polymorphism at the miR-502 binding site in the 3'-untranslated region of the histone methyltransferase SET8 is associated with hepatocellular carcinoma outcome. International Journal of Cancer 2012 131 5 1318 1322
54. Ding C., Li R., Peng J., Li S., Guo Z., A polymorphism at the miR-502 binding site in the 3 ′ untranslated region of the SET8 gene is associated with the outcome of small-cell lung cancer. Experimental and Therapeutic Medicine 2012 3 4 689 692
55. Wang C., Guo Z., Wu C., Li Y., Kang S., A polymorphism at the miR-502 binding site in the 3' untranslated region of the SET8 gene is associated with the risk of epithelial ovarian cancer. Cancer Genetics 2012 205 7-8 373 376
56. Guan X., Liu Z., Liu H., A functional variant at the miR-885-5p binding site of CASP3 confers risk of both index and second primary malignancies in patients with head and neck cancer. The FASEB Journal 2012
57. Landi D., Gemignani F., Naccarati A., Pardini B., Vodicka P., Vodickova L., Novotny J., Försti A., Hemminki K., Canzian F., Landi S., Polymorphisms within micro-RNA-binding sites and risk of sporadic colorectal cancer. Carcinogenesis 2008 29 3 579 584 2-s2.0-40949137791 10.1093/carcin/bgm304 (Pubitemid 351404875)
58. Landi D., Moreno V., Guino E., Polymorphisms affecting micro-RNA regulation and associated with the risk of dietary-related cancers: a review from the literature and new evidence for a functional role of rs17281995 (CD86) and rs1051690 (INSR), previously associated with colorectal cancer. Mutation Research 2011 717 1-2 109 115
59. Zhang L., Liu Y., Song F., Functional SNP in the microRNA-367 binding site in the 3 ′ UTR of the calcium channel ryanodine receptor gene 3 (RYR3) affects breast cancer risk and calcification. Proceedings of the National Academy of Science of the United States of America 2011 108 33 13653 13658
60. Luo J., Cai Q., Wang W., A microRNA-7 binding site polymorphism in HOXB5 leads to differential gene expression in bladder cancer. PLoS ONE 2012 7 6 e40127
61. Wynendaele J., Böhnke A., Leucci E., Nielsen S. J., Lambertz I., Hammer S., Sbrzesny N., Kubitza D., Wolf A., Gradhand E., Balschun K., Braicu I., Sehouli J., Darb-Esfahani S., Denkert C., Thomssen C., Hauptmann S., Lund A., Marine J. C., Bartel F., An illegitimate microRNA target site within the 3 ′ UTR of MDM4 affects ovarian cancer progression and chemosensitivity. Cancer Research 2010 70 23 9641 9649 2-s2.0-78649965834 10.1158/0008-5472.CAN- 10-0527
62. Ryan B. M., Robles A. I., Harris C. C., Genetic variation in microRNA networks: the implications for cancer research. Nature Reviews Cancer 2010 10 6 389 402 2-s2.0-77952918274 10.1038/nrc2867
63. Kim M. S., Oh J. E., Kim Y. R., Park S. W., Kang M. R., Kim S. S., Ahn C. H., Yoo N. J., Lee S. H., Somatic mutations and losses of expression of microRNA regulation-related genes AGO2 and TNRC6A in gastric and colorectal cancers. Journal of Pathology 2010 221 2 139 146 2-s2.0-77952756515 10.1002/path.2683
64. Horikawa Y., Wood C. G., Yang H., Zhao H., Ye Y., Gu J., Lin J., Habuchi T., Wu X., Single nucleotide polymorphisms of microRNA machinery genes modify the risk of renal cell carcinoma. Clinical Cancer Research 2008 14 23 7956 7962 2-s2.0-59449098051 10.1158/1078-0432.CCR-08-1199
65. Lin J., Horikawa Y., Tamboli P., Clague J., Wood C. G., Wu X., Genetic variations in microRNA-related genes are associated with survival and recurrence in patients with renal cell carcinoma. Carcinogenesis 2010 31 10 1805 1812 2-s2.0-77957785159 10.1093/carcin/bgq168
66. Sung H., Jeon S., Lee K. M., Common genetic polymorphisms of microRNA biogenesis pathway genes and breast cancer survival. BMC Cancer 2012 12, article 195
67. Liu J., Liu J., Wei M., Genetic variants in the microRNA machinery gene GEMIN4 are associated with risk of prostate cancer: a case-control study of the Chinese Han population. DNA and Cell Biology 2012 31 7 1296 1302
68. Campayo M., Navarro A., Viñolas N., Tejero R., Muñoz C., Diaz T., Marrades R., Cabanas M. L., Gimferrer J. M., Gascon P., Ramirez J., Monzo M., A dual role for KRT81: an miR-SNP associated with recurrence in Non-Small-Cell lung cancer and a novel marker of squamous cell lung carcinoma. PLoS ONE 2011 6 7 2-s2.0-79960858660 10.1371/journal.pone.0022509 e22509
69. Ma H., Yuan H., Yuan Z., Genetic variations in key microRNA processing genes and risk of head and neck cancer: a case-control study in Chinese population. PLoS ONE 2012 7 10 e47544
70. de Larrea C. F., Navarro A., Tejero R., Impact of MiRSNPs on survival and progression in patients with multiple myeloma undergoing autologous stem cell transplantation. Clinical Cancer Research 2012 18 13 3697 3704